Before last July, the FDA had logged 122 reports of suicides linked to
Chantix, including 37 reported by Pfizer
and 85 reported by
health professionals or consumers, Moore reported. After the 150 new Pfizer reports were added, the total jumped to 272.
In addition, the 589 new reports of severe problems included 102 cases of possible hostility and aggression, 156 cases of depression and 56 cases of possible psychosis. Those were mixed among the 26,000 reports of less-serious problems.